ATA226083A - Verfahren zur herstellung von neuen tricyclischen imidazolderivaten und ihrer pharmazeutisch verwendbaren salzen - Google Patents
Verfahren zur herstellung von neuen tricyclischen imidazolderivaten und ihrer pharmazeutisch verwendbaren salzenInfo
- Publication number
- ATA226083A ATA226083A AT0226083A AT226083A ATA226083A AT A226083 A ATA226083 A AT A226083A AT 0226083 A AT0226083 A AT 0226083A AT 226083 A AT226083 A AT 226083A AT A226083 A ATA226083 A AT A226083A
- Authority
- AT
- Austria
- Prior art keywords
- imidazole derivatives
- producing new
- pharmaceutical sales
- new tricyclic
- tricyclic imidazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7842415 | 1978-10-30 | ||
| US06/087,371 US4275066A (en) | 1978-10-30 | 1979-10-23 | Antireproductive tricyclic ortho-fused nitrogen containing compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA226083A true ATA226083A (de) | 1987-04-15 |
| AT384427B AT384427B (de) | 1987-11-10 |
Family
ID=26269380
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0697179A AT374803B (de) | 1978-10-30 | 1979-10-29 | Verfahren zur herstellung neuer tricyclischer orthokondensierter stickstoffhaeltiger verbindungen und ihrer pharmazeutisch verwendbaren salze |
| AT0226083A AT384427B (de) | 1978-10-30 | 1983-06-20 | Verfahren zur herstellung von neuen tricyclischen imidazolderivaten und ihrer pharmazeutisch verwendbaren salzen |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0697179A AT374803B (de) | 1978-10-30 | 1979-10-29 | Verfahren zur herstellung neuer tricyclischer orthokondensierter stickstoffhaeltiger verbindungen und ihrer pharmazeutisch verwendbaren salze |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4275066A (de) |
| JP (1) | JPS5562086A (de) |
| AT (2) | AT374803B (de) |
| AU (1) | AU532045B2 (de) |
| BE (1) | BE879729A (de) |
| CA (1) | CA1123827A (de) |
| CH (1) | CH650261A5 (de) |
| DE (1) | DE2943286A1 (de) |
| DK (1) | DK154298C (de) |
| FI (1) | FI66380C (de) |
| FR (1) | FR2440370A1 (de) |
| GB (1) | GB2039888B (de) |
| GR (1) | GR70248B (de) |
| HK (1) | HK24383A (de) |
| IE (1) | IE49625B1 (de) |
| LU (1) | LU81833A1 (de) |
| NL (1) | NL7907783A (de) |
| ZA (1) | ZA795743B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1211437A (en) * | 1981-08-12 | 1986-09-16 | Rene Borer | Benzazepines |
| US5302589A (en) * | 1992-08-07 | 1994-04-12 | Glaxo, Inc. | Heterocyclic inhibitors of 5-α-testosterone reductase |
| CN100432074C (zh) * | 2006-06-29 | 2008-11-12 | 浙江大学 | 2-芳基咪唑并[2,1-a]异喹啉的合成方法 |
| JP5412809B2 (ja) * | 2008-11-21 | 2014-02-12 | コニカミノルタ株式会社 | イミダゾール化合物の製造方法 |
| RU2657832C1 (ru) * | 2017-06-07 | 2018-06-15 | федеральное государственное автономное образовательное учреждение высшего образования "Южный федеральный университет" | Антидиабетическое средство |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3758480A (en) * | 1968-07-10 | 1973-09-11 | Mallinckrodt Chemical Works | S-triazolo(5,1-a)isoquinolines and derivatives thereof |
| US3775417A (en) * | 1971-08-05 | 1973-11-27 | Mallinckrodt Chemical Works | Selective hydrogenation of tri-and tetrazoloisoquinolines |
| GB1477302A (en) * | 1973-05-25 | 1977-06-22 | Lepetit Spa | Triazolo-isoindole and triazolo-isoquinoline derivatives and their manufacture and uses |
| RO66801A (fr) * | 1973-05-25 | 1979-08-15 | Lepetit Spa | Procede pour obtenir des derives des triazoloizoquinolines |
| US4075341A (en) * | 1974-05-24 | 1978-02-21 | Gruppo Lepetit S.P.A. | 2-Substituted phenyl-5-triazols [5,1-a] isoquinoline compounds |
| GB1484615A (en) * | 1974-11-23 | 1977-09-01 | Lepetit Spa | Tricyclic n-containing derivatives |
| IT1054655B (it) * | 1975-08-27 | 1981-11-30 | Lepetit Spa | Derivati condensati del l isochinolina |
| DE2707272C2 (de) * | 1977-02-19 | 1982-12-02 | Gruppo Lepetit S.p.A., 20158 Milano | 2-(p-Chlorphenyl)-s-triazolo [5,1-a] isochinolin |
| US4093728A (en) * | 1977-08-18 | 1978-06-06 | E. R. Squibb & Sons, Inc. | Triazoloisoindoles |
-
1979
- 1979-10-13 GR GR60257A patent/GR70248B/el unknown
- 1979-10-16 FI FI793215A patent/FI66380C/fi not_active IP Right Cessation
- 1979-10-18 AU AU51908/79A patent/AU532045B2/en not_active Ceased
- 1979-10-23 NL NL7907783A patent/NL7907783A/nl not_active Application Discontinuation
- 1979-10-23 US US06/087,371 patent/US4275066A/en not_active Expired - Lifetime
- 1979-10-26 IE IE2067/79A patent/IE49625B1/en unknown
- 1979-10-26 ZA ZA00795743A patent/ZA795743B/xx unknown
- 1979-10-26 DK DK452779A patent/DK154298C/da not_active IP Right Cessation
- 1979-10-26 DE DE19792943286 patent/DE2943286A1/de active Granted
- 1979-10-29 JP JP13971079A patent/JPS5562086A/ja active Granted
- 1979-10-29 CH CH9672/79A patent/CH650261A5/it not_active IP Right Cessation
- 1979-10-29 AT AT0697179A patent/AT374803B/de not_active IP Right Cessation
- 1979-10-29 LU LU81833A patent/LU81833A1/fr unknown
- 1979-10-29 GB GB7937388A patent/GB2039888B/en not_active Expired
- 1979-10-30 FR FR7926902A patent/FR2440370A1/fr active Granted
- 1979-10-30 CA CA338,698A patent/CA1123827A/en not_active Expired
- 1979-10-30 BE BE0/197894A patent/BE879729A/fr not_active IP Right Cessation
-
1983
- 1983-06-20 AT AT0226083A patent/AT384427B/de not_active IP Right Cessation
- 1983-07-28 HK HK243/83A patent/HK24383A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AT384427B (de) | 1987-11-10 |
| DE2943286C2 (de) | 1990-05-23 |
| DK154298C (da) | 1989-03-28 |
| FI66380C (fi) | 1984-10-10 |
| AU5190879A (en) | 1980-05-08 |
| AT374803B (de) | 1984-06-12 |
| FI793215A (fi) | 1980-05-01 |
| BE879729A (fr) | 1980-04-30 |
| IE49625B1 (en) | 1985-11-13 |
| IE792067L (en) | 1980-04-30 |
| CA1123827A (en) | 1982-05-18 |
| CH650261A5 (it) | 1985-07-15 |
| HK24383A (en) | 1983-08-05 |
| US4275066A (en) | 1981-06-23 |
| FI66380B (fi) | 1984-06-29 |
| DK154298B (da) | 1988-10-31 |
| LU81833A1 (fr) | 1980-05-07 |
| GR70248B (de) | 1982-09-01 |
| JPS5562086A (en) | 1980-05-10 |
| ATA697179A (de) | 1983-10-15 |
| ZA795743B (en) | 1980-10-29 |
| GB2039888A (en) | 1980-08-20 |
| FR2440370A1 (fr) | 1980-05-30 |
| FR2440370B1 (de) | 1982-10-29 |
| DK452779A (da) | 1980-05-01 |
| NL7907783A (nl) | 1980-05-02 |
| JPS6354716B2 (de) | 1988-10-28 |
| DE2943286A1 (de) | 1980-05-14 |
| AU532045B2 (en) | 1983-09-15 |
| GB2039888B (en) | 1982-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATA10882A (de) | Verfahren zur herstellung von neuen 6betahydroxyalkylpenicillansaeurederivaten | |
| AT375078B (de) | Verfahren zur herstellung von neuen indolizinderivaten | |
| AT369375B (de) | Verfahren zur herstellung von neuen 3-vinylcephalosporin-derivaten | |
| AT373871B (de) | Verfahren zur herstellung von neuen alpha -phenylpyrrolidin-2-methanol-derivaten | |
| ATA363379A (de) | Verfahren zur herstellung von neuen 4-amino-2piperidinochinazolinderivaten | |
| AT364097B (de) | Verfahren zur herstellung von neuen bicyclooctanderivaten | |
| AT384427B (de) | Verfahren zur herstellung von neuen tricyclischen imidazolderivaten und ihrer pharmazeutisch verwendbaren salzen | |
| AT373259B (de) | Verfahren zur herstellung von neuen 1oxadethiacephalosporin-derivaten | |
| AT371477B (de) | Verfahren zur herstellung von neuen 7-alpha -methoxycephalosporinderivaten | |
| AT380255B (de) | Verfahren zur herstellung von neuen benzo-as-triazin-derivaten | |
| AT370106B (de) | Verfahren zur herstellung von neuen penicillansaeurederivaten | |
| AT373896B (de) | Verfahren zur herstellung von neuen ergopeptidalkaloidderivaten | |
| AT374798B (de) | Verfahren zur herstellung von neuen aminoisochinolinderivaten | |
| AT370725B (de) | Verfahren zur herstellung von neuen 16-methoxy-16-methyl-prostaglandin-e1-derivaten | |
| AT371439B (de) | Verfahren zur herstellung von neuen n-substituierten moranolinderivaten und ihrer salze | |
| AT364458B (de) | Verfahren zur herstellung von neuen oleandomycinderivaten | |
| AT372077B (de) | Verfahren zur herstellung von neuen benzylidenderivaten | |
| AT378534B (de) | Verfahren zur herstellung von neuen ergopeptinderivaten | |
| AT375648B (de) | Verfahren zur herstellung von neuen carbostyrilderivaten | |
| AT369378B (de) | Verfahren zur herstellung von neuen 3-thiovinyl-cephalosporinderivaten | |
| AT374167B (de) | Verfahren zur herstellung von neuen naphthacenderivaten | |
| AT374480B (de) | Verfahren zur herstellung von neuen 3-thiovinylcephalosporinderivaten | |
| AT374481B (de) | Verfahren zur herstellung von neuen 3-thiovinylcephalosporinderivaten | |
| ATA451583A (de) | Verfahren zur herstellung von neuen 1-phenaethylimidazol-derivaten | |
| ATA246583A (de) | Verfahren zur herstellung von neuen carbostyrilderivaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee |